NIKE, Inc. (NKE) Stock Forecast
Data as of Jun 16, 2026Consumer Cyclical · Current price $45.25 (+0.13%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 12, 2026 | Randal Konik | Jefferies | $110.00 | +143.1% |
| Dec 19, 2025 | Peter McGoldrick | Stifel Nicolaus | $65.00 | +43.6% |
| Dec 19, 2025 | Brooke Roach | Goldman Sachs | $77.00 | +70.2% |
| Dec 19, 2025 | Adrienne Yih | Barclays | $64.00 | +41.4% |
| Dec 19, 2025 | Jay Sole | UBS | $62.00 | +37.0% |
| Dec 15, 2025 | Brooke Roach | Goldman Sachs | $89.00 | +96.7% |
| Dec 10, 2025 | Christina Fernandez | UBS | $75.00 | +65.7% |
| Oct 14, 2025 | Bob Drbul | BTIG | $100.00 | +121.0% |
| Oct 1, 2025 | Anna Andreeva | Piper Sandler | $84.00 | +85.6% |
| Oct 1, 2025 | Adrienne Yih | Barclays | $70.00 | +54.7% |
| Oct 1, 2025 | Alex Straton | Morgan Stanley | $72.00 | +59.1% |
| Sep 19, 2025 | Jay Sole | UBS | $71.00 | +56.9% |
| Jun 27, 2025 | Jay Sole | UBS | $63.00 | +39.2% |
| Jan 10, 2025 | Anna Andreeva | Piper Sandler | $90.00 | +98.9% |
| Oct 10, 2024 | Katherine Griffin | Griffin | $90.00 | +98.9% |
| Oct 10, 2024 | Joseph Civello | Truist Financial | $97.00 | +114.4% |
| Oct 2, 2024 | Jay Sole | UBS | $82.00 | +81.2% |
| Oct 2, 2024 | Joseph Civello | Truist Financial | $83.00 | +83.4% |
| Sep 30, 2024 | Randal Konik | Jefferies | $85.00 | +87.8% |
| Sep 25, 2024 | Piral Dadhania | RBC Capital | $85.00 | +87.8% |
Top Analysts Covering NKE
NKE vs Sector & Market
| Metric | NKE | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.53 | 2.52 | 2.41 |
| Analyst Count | 43 | 13 | 19 |
| Target Upside | +42.8% | +387.3% | +17.1% |
| P/E Ratio | 29.74 | 13.90 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $11.37B | $11.52B | $11.70B | 13 |
| 2026-11-28 | $12.16B | $12.34B | $12.58B | 6 |
| 2027-02-28 | $11.30B | $11.46B | $11.69B | 6 |
| 2027-05-28 | $11.04B | $11.19B | $11.42B | 6 |
| 2027-05-31 | $44.98B | $46.68B | $50.19B | 27 |
| 2027-08-28 | $12.08B | $12.25B | $12.50B | 6 |
| 2027-11-28 | $12.91B | $13.09B | $13.35B | 7 |
| 2028-02-28 | $12.05B | $12.22B | $12.46B | 6 |
| 2028-05-28 | $11.76B | $11.93B | $12.17B | 7 |
| 2028-05-31 | $48.73B | $48.81B | $48.89B | 27 |
| 2029-05-31 | $51.19B | $52.34B | $54.57B | 13 |
| 2030-05-31 | $56.98B | $58.27B | $60.74B | 14 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $0.41 | $0.45 | $0.49 | 11 |
| 2026-11-28 | $0.58 | $0.60 | $0.61 | 7 |
| 2027-02-28 | $0.46 | $0.47 | $0.48 | 4 |
| 2027-05-28 | $0.26 | $0.27 | $0.27 | 4 |
| 2027-05-31 | $1.54 | $1.86 | $2.85 | 26 |
| 2027-08-28 | $0.64 | $0.65 | $0.67 | 5 |
| 2027-11-28 | $0.77 | $0.79 | $0.81 | 8 |
| 2028-02-28 | $0.68 | $0.69 | $0.71 | 5 |
| 2028-05-28 | $0.47 | $0.48 | $0.49 | 5 |
| 2028-05-31 | $1.45 | $2.39 | $3.86 | 24 |
| 2029-05-31 | $2.72 | $2.80 | $2.95 | 18 |
| 2030-05-31 | $4.13 | $4.25 | $4.49 | 11 |
Frequently Asked Questions
What is the analyst consensus for NKE?
The consensus among 43 analysts covering NIKE, Inc. (NKE) is Hold with an average price target of $75.56.
What is the highest price target for NKE?
The highest price target for NKE is $195.00, set by Brian Nagel at Oppenheimer on 2021-07-26.
What is the lowest price target for NKE?
The lowest price target for NKE is $51.00, set by Kevin Mcveigh at Credit Suisse on 2023-01-12.
How many analysts cover NKE?
43 analysts have issued ratings for NIKE, Inc. in the past 12 months.
Is NKE a buy or sell right now?
Based on 43 analyst ratings, NKE has a consensus rating of Hold (2.53/5) with a +42.8% upside to the consensus target of $75.56.
What are the earnings estimates for NKE?
Analysts estimate NKE will report EPS of $0.45 for the period ending 2026-08-28, with revenue estimated at $11.52B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.